Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J/McNeil Done With Post-Recall Personnel Changes – CEO Weldon

Executive Summary

Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.

You may also be interested in...

J&J, FDA Share Blame On Motrin "Phantom Recall"

FDA's Sharfstein says agency "could've done better" in asking questions after it was contacted by J&J about problems with Motrin.

J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires

Johnson & Johnson consumer products executive Colleen Goggins' pending retirement could signal a larger executive-level overhaul at the firm

J&J Keeps Expectations Conservative For OTC Manufacturing Remediation

Johnson & Johnson expects the resumption of manufacturing the children's OTC drugs the firm's McNeil Consumer Healthcare business recalled this year may be as far off as April 2011


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts